CUMBERLAND PHARMACEUTICALS INC Contracts & Agreements

Revolving Credit Loan Agreement, dated as of September 5, 2023, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on September 6, 2023)

Amendment Number 3 to the Amended and Restated 2007 Long-Term Incentive Compensation Plan, incorporated herein by reference to Appendix A of the Companys Schedule 14A (File No.:... (Filed With SEC on August 11, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Jim Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Todd Anthony and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 12, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Jim Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between John M. Hamm and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)

Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Todd Anthony and Cumberland Pharmaceuticals Inc (Filed With SEC on March 15, 2023)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 13, 2023)

Employment Agreement dated March (Filed With SEC on March 13, 2023)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc., incorporated herein by reference to... (Filed With SEC on March 13, 2023)

Employment Agreement dated March (Filed With SEC on March 13, 2023)

Ninth Amendment to Revolving Credit Loan Agreement, dated as of September 29, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on November 14, 2022)

Eighth Amendment to Revolving Credit Loan Agreement, dated as of June 30, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on August 12, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between James L. Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (Filed With SEC on May 13, 2022)

Seventh Amendment to Revolving Credit Loan Agreement, dated as of March 31, 2022, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on May 13, 2022)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 11, 2022)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between Martin E. Cearnal and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between (Filed With SEC on March 11, 2022)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 11, 2022)

Fifth Amendment to the Revolving Credit Note and Sixth Amendment to Revolving Credit Loan Agreement, dated as of December 31, 2021, by and between Cumberland Pharmaceuticals Inc.... (Filed With SEC on March 11, 2022)

Lease Agreement, dated November 15, 2021, by and between Cumberland Pharmaceuticals Inc. and 1600 West End Avenue Partners, LLC (Filed With SEC on March 11, 2022)

Asset Purchase Agreement, dated December 31, 2021, by and among Cumberland Pharmaceuticals Inc. and Kyowa Kirin, Inc (Filed With SEC on January 6, 2022)

Amendment No. 1 to the At Market Issuance Sales Agreement, dated December 27, 2021, by and between Cumberland Pharmaceuticals Inc. and B. Riley Securities, Inc. (formerly B. Riley... (Filed With SEC on December 27, 2021)

Fourth Amendment to Revolving Credit Note and Fifth Amendment to Revolving Credit Loan Agreement, dated as of October 28, 2021, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 12, 2021)

Exhibit 10.16 dated May 14, 2021 (Filed With SEC on May 14, 2021)

Description of Cumberland Pharmaceutical's Common Stock (Filed With SEC on March 12, 2021)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 12, 2021)

Employment Agreement dated March (Filed With SEC on March 12, 2021)

Employment Agreement dated March 8, 2021, effective as of January 1, 2021, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 12, 2021)

Third Amendment to Revolving Credit Note and Fourth Amendment to Revolving Credit Loan Agreement, dated as of October 7, 2020 by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 13, 2020)

Amendment Number 2 to the Amended and Restated 2007 Long-Term Incentive Compensation Plan (Filed With SEC on August 14, 2020)

Amendment Number 2 to the Amended and Restated 2007 Director's Incentive Compensation Plan (Filed With SEC on August 14, 2020)

Payment Protection Program (Filed With SEC on August 14, 2020)

Employment Agreement dated March (Filed With SEC on March 20, 2020)

First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on May 15, 2019)

Second Amendment to Revolving Credit Note and Third Amendment to Revolving Credit Loan Agreement, dated as of May 10, 2019 by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on May 15, 2019)

Employment Agreement dated March (Filed With SEC on March 12, 2019)

Asset Purchase Agreement, dated November 1, 2018, by and among Cumberland Pharmaceuticals Inc., Theravance Biopharma Ireland Limited, and Theravance Biopharma US (Filed With SEC on November 16, 2018)

First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on November 14, 2018)

First Amendment to Revolving Credit Note and Second Amendment to Revolving Credit Loan Agreement, dated as of October 17, 2018, by and between Cumberland Pharmaceuticals Inc. and... (Filed With SEC on October 19, 2018)

Amendment to Revolving Credit Loan Agreement, by and between Pinnacle Bank and Cumberland Pharmaceutical Inc., dated August 1 (Filed With SEC on August 14, 2018)

Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)

Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between Martin E. Cearnal and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)

Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)

Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between Michael P. Bonner and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)

Employment Agreement dated March 9, 2018, effective as of January 1, 2018, by and between James L. Herman and Cumberland Pharmaceuticals Inc (Filed With SEC on March 9, 2018)

Revolving Credit Loan Agreement, dated July 31, 2017, by and between Cumberland Pharmaceuticals Inc. and Pinnacle Bank (Filed With SEC on November 8, 2017)

# # # # (Filed With SEC on March 13, 2017)

SECOND AMENDMENT TO REVOLVING CREDIT LOAN AGREEMENT (Filed With SEC on March 13, 2017)

FIRST AMENDMENT TO REVOLVING CREDIT LOAN AGREEMENT (Filed With SEC on November 3, 2016)

# # # # (Filed With SEC on March 14, 2016)

# # # # # # # # (Filed With SEC on March 14, 2016)

# # # # (Filed With SEC on March 14, 2016)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC (Filed With SEC on March 14, 2016)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. THIRD AMENDMENT TO OFFICE LEASE... (Filed With SEC on November 6, 2015)

# # # # (Filed With SEC on March 9, 2015)

REVOLVING CREDIT LOAN AGREEMENT dated as of June 26, 2014 between CUMBERLAND PHARMACEUTICALS INC., as Borrower and SUNTRUST BANK the Lender Table of Contents (Filed With SEC on August 8, 2014)

# # # # (Filed With SEC on March 11, 2014)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC Omeclamox-PaK PROMOTION AGREEMENT... (Filed With SEC on March 11, 2014)

WAIVER (Filed With SEC on March 11, 2014)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC FIRST AMENDMENT TO EXCLUSIVE... (Filed With SEC on June 3, 2013)

CUMBERLAND PHARMACEUTICALS INC. AMENDED AND RESTATED 2007 DIRECTORS' INCENTIVE PLAN NON-STATUTORY STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2013)

CUMBERLAND PHARMACEUTICALS INC. AMENDED AND RESTATED 2007 LONG-TERM INCENTIVE COMPENSATION PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2013)

CUMBERLAND PHARMACEUTICALS INC. AMENDED AND RESTATED 2007 LONG-TERM INCENTIVE COMPENSATION PLAN NON-STATUTORY STOCK OPTION AGREEMENT (Filed With SEC on March 12, 2013)

# # # # (Filed With SEC on March 12, 2013)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. (Filed With SEC on March 12, 2013)

FIRST AMENDMENT TO FIFTH AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on March 12, 2013)

WAIVER AND SECOND AMENDMENT TO FIFTH AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on March 12, 2013)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately withthe SEC. THIRD AMENDMENT TO AMENDED AND... (Filed With SEC on August 9, 2012)

Bayer HealthCare AMENDMENT (Filed With SEC on August 9, 2012)

# # # # (Filed With SEC on March 7, 2012)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. PACKAGING AGREEMENT (Filed With SEC on March 7, 2012)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. ASSET PURCHASE AND ROYALTY... (Filed With SEC on November 22, 2011)

___/s/ A. J. Kazimi By: A.J. Kazimi Chief Executive OfficerAccepted as to all terms and conditions as of the 11th of October, 2011: /s/ Rick S. Greene (Filed With SEC on October 18, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on August 8, 2011)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. THIRD AMENDMENT TO MANUFACTURING... (Filed With SEC on June 24, 2011)

Acetaminophen Poisoning (Filed With SEC on March 11, 2011)

Financial Statements (Filed With SEC on May 17, 2010)

FIFTH AMENDMENT TO SERVICE AGREEMENT (Filed With SEC on April 6, 2010)

By: /s/ Jean W. Marstiller Corporate SecretaryAccepted as to all terms and conditions as of the 25th of March, 2010: /s/ A.J. Kazimi Exhibit A Option Agreement (Filed With SEC on March 29, 2010)

By: /s/ A.J. Kazimi Chief Executive OfficerAccepted as to all terms and conditions as of the 25th of March, 2010: /s/ Jean W. Marstiller Exhibit A Option Agreement (Filed With SEC on March 29, 2010)

By: /s/ A.J. Kazimi Chief Executive OfficerAccepted as to all terms and conditions as of the 25th of March, 2010: /s/ Leo Pavliv Exhibit A Option Agreement (Filed With SEC on March 29, 2010)

By: /s/ A.J. Kazimi Chief Executive OfficerAccepted as to all terms and conditions as of the 25th of March, 2010: /s/ David L. Lowrance Exhibit A Option Agreement (Filed With SEC on March 29, 2010)

By: /s/ A.J. Kazimi Chief Executive OfficerAccepted as to all terms and conditions as of the 25th of March, 2010: /s/ Martin E. Cearnal Exhibit A Option Agreement (Filed With SEC on March 29, 2010)

Acetaminophen Poisoning (Filed With SEC on March 19, 2010)

EX-23.1 CONSENT OF KPMG LLP (Filed With SEC on July 29, 2009)

EX-10.13.1 EMPLOYMENT AGREEMENT - LEO PAVLIV (Filed With SEC on July 17, 2009)

EX-10.26 EMPLOYMENT AGREEMENT - MARTIN E. CEARNAL (Filed With SEC on July 17, 2009)

Pain and Fever (Filed With SEC on May 12, 2009)

Pain and Fever (Filed With SEC on February 18, 2009)

EX-10.7 Distribution Services Agreement (Filed With SEC on August 12, 2008)

EX-10.9.2 SECOND AMENDMENT TO KRISTALOSE AGREEMENT (Filed With SEC on August 12, 2008)

EX-10.26 Employment Agreement effective as of July 1, 2008 by and between Martin E. Cearnal and Cumberland Pharmaceuticals Inc (Filed With SEC on August 12, 2008)

Ex-10.25 Manufacturing Agreement (Filed With SEC on June 20, 2008)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDMENT TO... (Filed With SEC on May 21, 2008)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. THIRD AMENDMENT TO CONTRACT... (Filed With SEC on May 21, 2008)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. AMENDMENT TO KRISTALOSE... (Filed With SEC on May 21, 2008)

THIRD AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on May 21, 2008)

FIRST AMENDMENT TO OFFICE LEASE AGREEMENT (Filed With SEC on May 21, 2008)

SECOND AMENDMENT TO AMENDED AND RESTATED LEASE AGREEMENT (Filed With SEC on May 21, 2008)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. MANUFACTURING AGREEMENT (Filed With SEC on May 21, 2008)

EX-10.11 Employment Agreement effective as of January 1, 2008 by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc (Filed With SEC on February 1, 2008)

EX-10.12 Employment Agreement effective as of January 1, 2008by and between Jean W. Marstiller and Cumberland Pharmaceuticals Inc (Filed With SEC on February 1, 2008)

EX-10.13 Employment Agreement effective as of January 1, 2008 by and between Leo Pavliv and Cumberland Pharmaceuticals Inc (Filed With SEC on February 1, 2008)

EX-10.14 Employment Agreement effective as of January 1, 2008 by and between J. William Hix and Cumberland Pharmaceuticals Inc (Filed With SEC on February 1, 2008)

EX-10.15 Employment Agreement effective as of January 1, 2008 by and between David L. Lowrance and Cumberland Pharmaceuticals Inc (Filed With SEC on February 1, 2008)

EX-4.1 SPECIMEN COMMON STOCK CERTIFICATE (Filed With SEC on August 6, 2007)

EX-10.1 MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on August 6, 2007)

Ex-1.1 Form of Underwriting Agreement (Filed With SEC on July 23, 2007)

Ex-10.8 Strategic Alliance Agreement (Filed With SEC on July 23, 2007)

Ex-10.16.3 Second Amendment to Second Amended and Restated Loan Agreement (Filed With SEC on July 23, 2007)

CUMBERLAND PHARMACEUTICALS INC. 2007 DIRECTORS INCENTIVE PLAN NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. MANUFACTURING AND SUPPLY... (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FIRST AMENDMENT TO MANUFACTURING... (Filed With SEC on July 11, 2007)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. (Filed With SEC on July 11, 2007)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FIRST AMENDMENT TO CONTRACT... (Filed With SEC on July 11, 2007)

SECOND AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENT (Filed With SEC on July 11, 2007)

* Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. DISTRIBUTION SERVICES AGREEMENT (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. KRISTALOSE AGREEMENT (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. License Agreement (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDED AND RESTATED LOAN... (Filed With SEC on July 11, 2007)

FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on July 11, 2007)

*Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. (Filed With SEC on July 11, 2007)

CUMBERLAND PHARMACEUTICALS INC. 2007 LONG-TERM INCENTIVE COMPENSATION PLAN INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on July 11, 2007)

CUMBERLAND PHARMACEUTICALS INC. 2007 LONG-TERM INCENTIVE COMPENSATION PLAN NONSTATUTORY STOCK OPTION AGREEMENT (Filed With SEC on July 11, 2007)

Ex-4.3 Stock Purchase Warrant, Issued to S.C.O.U.T. Healthcare Fund L.P (Filed With SEC on June 22, 2007)

Ex-10.18 2007 Long-Term Incentive Compensation Plan of Cumberland Pharmaceuticals Inc (Filed With SEC on June 22, 2007)

Ex-10.19 2007 Directors' Compensation Plan of Cumberland Pharmaceuticals Inc (Filed With SEC on June 22, 2007)

EX-4.2 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 1, 2007)

EX-4.4 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 1, 2007)

EX-4.5 FORM OF OPTION AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.1 MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.2 NOVATION AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.3 FIRST AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.4 CARDINAL HEALTH CONTRACT SALES AND SERVICE (Filed With SEC on May 1, 2007)

EX-10.5 FIRST AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.6 CONSENT TO ASSIGNMENT (Filed With SEC on May 1, 2007)

EX-10.7 DISTRIBUTION SERVICES AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.8 STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.9 KRISTALOSE AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.10 LICENSE AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.11 EMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.12 EMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.13 EMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.14 EMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.15 EMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.17 1999 STOCK OPTION PLAN (Filed With SEC on May 1, 2007)

EX-10.20 FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.21 LEASE AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.23 AMENDED AND RESTATED LEASE AGREEMENT (Filed With SEC on May 1, 2007)

EX-10.24 FIRST AMENDMENT TO AMENDED AND RESTATED LEASE AGREEMENT (Filed With SEC on May 1, 2007)

Category

Industry

Companies

Contracts

CUMBERLAND PHARMACEUTICALS INC Contracts & Agreements